404 related articles for article (PubMed ID: 8959078)
1. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
2. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
3. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
[TBL] [Abstract][Full Text] [Related]
4. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
5. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
[TBL] [Abstract][Full Text] [Related]
6. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
7. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
8. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.
Nomikos P; Buchfelder M; Fahlbusch R
Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854
[TBL] [Abstract][Full Text] [Related]
9. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels.
Biermasz NR; Dulken HV; Roelfsema F
Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449
[TBL] [Abstract][Full Text] [Related]
11. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.
Jane JA; Starke RM; Elzoghby MA; Reames DL; Payne SC; Thorner MO; Marshall JC; Laws ER; Vance ML
J Clin Endocrinol Metab; 2011 Sep; 96(9):2732-40. PubMed ID: 21715544
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
Valdemarsson S; Ljunggren S; Cervin A; Svensson C; Isaksson A; Nordström CH; Siesjö P
Scand J Clin Lab Invest; 2001; 61(6):459-70. PubMed ID: 11681536
[TBL] [Abstract][Full Text] [Related]
15. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
16. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
[TBL] [Abstract][Full Text] [Related]
17. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
18. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
[TBL] [Abstract][Full Text] [Related]
19. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.
Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Tamburrano G; Cantore G
Endocr Relat Cancer; 2003 Dec; 10(4):611-9. PubMed ID: 14713271
[TBL] [Abstract][Full Text] [Related]
20. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]